Cargando…
SB225002 inhibits prostate cancer invasion and attenuates the expression of BSP, OPN and MMP-2
The mechanisms of malignant cell metastasis to secondary sites are complex and multifactorial. Studies have demonstrated that small integrin-binding ligand N-linked glycoproteins (SIBLINGs), particularly bone sialoprotein (BSP) and osteopontin (OPN), are involved in neoplastic growth and metastasis....
Autores principales: | Xu, Meng, Jiang, Huamao, Wang, Haiguang, Liu, Jiajie, Liu, Baohao, Guo, Zhongqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072299/ https://www.ncbi.nlm.nih.gov/pubmed/29917166 http://dx.doi.org/10.3892/or.2018.6504 |
Ejemplares similares
-
Therapeutic inhibition of CXC chemokine receptor 2 by SB225002 attenuates LPS-induced acute lung injury in mice
por: Cao, Qing, et al.
Publicado: (2017) -
Interleukin-8 promotes prostate cancer bone metastasis through upregulation of bone sialoprotein
por: Liu, Baohao, et al.
Publicado: (2019) -
Combining TMZ and SB225002 induces changes of CXCR2 and VEGFR signalling in primary human endothelial cells in vitro
por: Urbantat, Ruth M., et al.
Publicado: (2022) -
SB225002 Promotes Mitotic Catastrophe in Chemo-Sensitive and -Resistant Ovarian Cancer Cells Independent of p53 Status In Vitro
por: Du, Meirong, et al.
Publicado: (2013) -
SB225002 Induces Cell Death and Cell Cycle Arrest in Acute Lymphoblastic Leukemia Cells through the Activation of GLIPR1
por: de Vasconcellos, Jaíra Ferreira, et al.
Publicado: (2015)